-transparent.png){kind=logo}
Intravenous administration of the dopamine antagonists domperidone and metoclopramide elevates canine plasma beta-endorphin immunoreactivity. Pretreatment with dopamine, but not dexamethasone, inhibits this effect. Sephadex G-50 chromatography shows that this response is due to beta-endorphin-like peptides, not beta-lipotropin. These findings indicate that pituitary beta-endorphin secretion is tonically inhibited by dopamine and suggest that the intermediate lobe is the source of this secretion.
Related Publications
B Sharp, and
R Ross, and
E Levin, and
J Sowers
September 1979,
Science (New York, N.Y.),
B Sharp, and
R Ross, and
E Levin, and
J Sowers
June 1982,
Experientia,
B Sharp, and
R Ross, and
E Levin, and
J Sowers
August 1990,
Experimental and clinical endocrinology,
B Sharp, and
R Ross, and
E Levin, and
J Sowers
January 1987,
British journal of obstetrics and gynaecology,
B Sharp, and
R Ross, and
E Levin, and
J Sowers
February 1984,
Life sciences,
B Sharp, and
R Ross, and
E Levin, and
J Sowers
December 1993,
Journal of sports sciences,
B Sharp, and
R Ross, and
E Levin, and
J Sowers
June 1987,
Medicine and science in sports and exercise,
B Sharp, and
R Ross, and
E Levin, and
J Sowers
April 1985,
Research communications in chemical pathology and pharmacology,
B Sharp, and
R Ross, and
E Levin, and
J Sowers
June 1988,
Endocrinologia experimentalis,
B Sharp, and
R Ross, and
E Levin, and
J Sowers
January 1984,
Psychosomatic medicine,
